Skip to Content
  • AstraZeneca Gets the Bad News

    After writing about Merck’s successes (so far) in immuno-oncology, it’s time to write about AstraZeneca’s failure. When the rumors started fly… Read More
  • The Keytruda Story

    This is a good history of Keytruda, the Merck immuno-oncology blockbuster, from David Shaywitz. Most big drugs have a tangled history, and this one is certainly… Read More
  • Glioblastoma Is Bad News, Period

    Everyone keeping up with the news will have heard about Sen. McCain’s diagnosis of glioblastoma multiforme (GBM). This is not good news at all; GBM is a v… Read More
  • Chaos at AstraZeneca

    What on earth is going on over at AstraZeneca? The company has had plenty of wild ups and downs over the years, and managed to fight off a takeover attempt by P… Read More
  • An Approval Like No Other

    Merck got an unusual approval at the FDA recently, for its Keytruda antibody in oncology. What’s new about it is that it is the first approval that’ Read More
Page 1 of 3712345...102030...Last »